Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 6:2020:8868107.
doi: 10.1155/2020/8868107. eCollection 2020.

Essential Oil and Juice from Bergamot and Sweet Orange Improve Acne Vulgaris Caused by Excessive Androgen Secretion

Affiliations

Essential Oil and Juice from Bergamot and Sweet Orange Improve Acne Vulgaris Caused by Excessive Androgen Secretion

Peng Sun et al. Mediators Inflamm. .

Abstract

Acne vulgaris is one of the most common chronic inflammatory skin diseases. Bergamot and sweet orange are rich in nutritional and functional components, which exhibit antioxidant, anti-inflammatory, and antiapoptotic effect. The aim of this study was to evaluate the potential effect of bergamot and sweet orange (juice and essential oil) on acne vulgaris caused by excessive secretion of androgen. Eighty male golden hamsters were randomly divided into 10 groups and received low or high dose of bergamot and sweet orange juice and essential oil, physiological saline, and positive drugs for four weeks, respectively. Results showed that all interventions could improve acne vulgaris by reducing the growth rate of sebaceous gland spots, inhibiting TG accumulation, decreasing the release of inflammatory cytokines (notably reducing IL-1α levels), promoting apoptosis in the sebaceous gland, and decreasing the ratio of T/E2. Among them, bergamot and orange essential oil may have better effects (dose dependent) on alleviating acne vulgaris than the corresponding juice. In view of the large population of acne patients and the widespread use of sweet orange and bergamot, this study is likely to exert an extensive and far-reaching influence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
Effect of different treatments on the growth rate of sebaceous gland spots: (a) the growth rate of sebaceous gland spots in the first week, (b) the growth rate of sebaceous gland spots in the second week, (c) the growth rate of sebaceous gland spots in the third week, and (d) the growth rate of sebaceous gland spots in the fourth week. Values are expressed as the mean ± SD (n = 8). Data with different letters indicate significant differences (P < 0.05).
Figure 2
Figure 2
Effect of different treatments on serum sex hormone levels: (a) serum T level, (b) serum E2 level, and (c) the ratio of T/E2. Values are expressed as the mean ± SD (n = 8). Significance was defined as P < 0.05.
Figure 3
Figure 3
Effect of different treatments on the level of TG. Values are expressed as the mean ± SD (n = 8). Data with different letters indicate significant differences (P < 0.05).
Figure 4
Figure 4
Effect of different treatments on the level of serum inflammatory factors in the golden hamster: (a) IL-1α level, (b) IL-6 level, and (c) TNF-α level. Values are expressed as the mean ± SD (n = 8). Data with different letters indicate significant differences (P < 0.05).
Figure 5
Figure 5
Effect of different treatments on the level of serum MMP-2 and MMP-9 in the golden hamster: (a) MMP-2 level and (b) MMP-9 level. Values are expressed as the mean ± SD (n = 8). Significance was defined as P < 0.05.
Figure 6
Figure 6
Effect of different treatments in the golden hamster on the activity of caspase-3. Values are expressed as the mean ± SD (n = 8). Significance was defined as P < 0.05.

Similar articles

Cited by

References

    1. Meixner D., Schneider S., Krause M., Sterry W. Acne inversa. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2008;6(3):189–196. doi: 10.1111/j.1610-0387.2007.06492.x. - DOI - PubMed
    1. Shalita A. R. Acne: clinical presentations. Clinics in Dermatology. 2004;22(5):385–386. doi: 10.1016/j.clindermatol.2004.03.012. - DOI - PubMed
    1. de Vries F. M. C., Meulendijks A. M., Driessen R. J. B., van Dooren A. A., Tjin E. P. M., van de Kerkhof P. C. M. The efficacy and safety of non-pharmacological therapies for the treatment of acne vulgaris: a systematic review and best-evidence synthesis. Journal of the European Academy of Dermatology and Venereology. 2018;32(7):1195–1203. doi: 10.1111/jdv.14881. - DOI - PubMed
    1. Williams H. C., Dellavalle R. P., Garner S. Acne vulgaris. The Lancet. 2012;379(9813):361–372. doi: 10.1016/S0140-6736(11)60321-8. - DOI - PubMed
    1. Tan J. K. L., Stein Gold L. F., Alexis A. F., Harper J. C. Current concepts in acne pathogenesis: pathways to inflammation. Seminars in Cutaneous Medicine and Surgery. 2018;37(3S):S60–S62. doi: 10.12788/j.sder.2018.024. - DOI - PubMed